Madhukar H. Trivedi

Cognitive Neuroscience · 2000–2022

A researcher in the Science corpus: 20 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Cognitive Neuroscience — 45 citations into it
• Clinical Psychology — 9 citations into it

Whom Madhukar H. Trivedi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Landis
2. T. Carmody
3. Gary G. Koch

Who trusts Madhukar H. Trivedi overall

1. Punit Shah
2. V. Krishnan
3. Joelle Pineau
4. Andreas Ströhle
5. Maurizio Fava
6. E. Nestler
7. G. Sanacora
8. Justin Riddle

Papers from Madhukar H. Trivedi's perspective

Ordered by how strongly the researchers Madhukar H. Trivedi trusts endorse each paper. Same corpus, a different order for every researcher.

1. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (New England Journal of Medicine)
2. The measurement of observer agreement for categorical data.
3. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. (The British journal of psychiatry : the journal of mental science)
4. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
5. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). (Journal of the American Medical Association (JAMA))
6. The PHQ-9 (Journal of general internal medicine)
7. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. (Biological Psychiatry)
8. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. (Archives of General Psychiatry)
9. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. (Archives of General Psychiatry)
10. The PHQ-9: validity of a brief depression severity measure. (Journal of general internal medicine)

Their papers

• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. (2006) — 3,689 citations
• Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. (2008) — 887 citations
• Time for united action on depression: a Lancet-World Psychiatric Association Commission. (2022) — 788 citations
• Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. (2019) — 642 citations
• Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data (2018) — 445 citations
• Harmonization of cortical thickness measurements across scanners and sites (2017) — 1,415 citations
• Cross-trial prediction of treatment outcome in depression: a machine learning approach. (2016) — 586 citations
• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. (2009) — 642 citations
• Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2008) — 98 citations
• Examining sensory quadrants in autism (2007) — 86 citations
• Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report (2006) — 3,189 citations
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. (2006) — 2,735 citations
• Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. (2006) — 1,014 citations
• Medication augmentation after the failure of SSRIs for depression. (2006) — 990 citations
• Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder (2006) — 673 citations
• Exercise treatment for depression: efficacy and dose response. (2005) — 1,410 citations
• The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation (2004) — 927 citations
• Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. (2004) — 1,030 citations
• Physical activity dose-response effects on outcomes of depression and anxiety. (2001) — 896 citations
• A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. (2000) — 1,335 citations